, an inhibitor of cyclin-dependent kinases, which is responsible for p53-dependent cell cycle arrest or dierentiation (el-Deiry et al., 1993; Harper et al., 1993; Liu et al., 1996; Xiong et al., 1993) . However, it is still not certain what exact function p53 plays in apoptosis. Several studies have provided evidence that only certain domains of p53 are required for apoptosis, e.g., the N-terminal 22 amino acids are dispensable (Chen et al., 1996) but the sequencespeci®c DNA binding domain is required (for reviews, see Gottlieb and Oren, 1996; Ko and Prives, 1996; Levine, 1997) . Deletion of the C-terminal regulatory domain reduces p53 apoptotic activity (Chen et al., 1996; Wang et al., 1996) , as does a double point mutation at residues 22 and 23 (Chen et al., 1996; Haupt et al., 1995) , which also diminishes p53 transcriptional activity . In addition, several studies have provided evidence that p53 may have a transactivation-independent function in apoptosis (Caelles et al., 1994; Haupt et al., 1995; Wagner et al., 1994) .
Recently, the proline-rich region between residues 60 and 90, which contains ®ve`PXXP' motifs (where P represents proline and X any amino acid), was found to be necessary for ecient growth suppression (Walker and Levine, 1996) , serving as a docking site for transactivation-independent growth arrest induced by GAS1 (Ruaro et al., 1997) . In addition, the prolinerich region is required for the murine temperaturesensitive p53(val135) to induce apoptosis in adenovirus E1A-transformed cells (Sakamuro et al., 1997) .
To further examine the importance of the prolinerich region in human p53, p53(D62 ± 91), which lacks all ®ve PXXP motifs, was generated and inducibly expressed in H1299 using the tetracycline-inducible expression system as we have used previously (Chen et al., 1996) . H1299 is a p53-null non-small cell lung carcinoma cell line. Nine stable cell lines that inducibly express p53(D62 ± 91) were established. Western blot analysis of four cell lines, one expressing wild-type and three expressing mutant p53, is shown in Figure 1a . p53(D62 ± 91)-1 is a low p53 producer, and p53(D62 ± 91)-5 and -6 are high p53 producers when compared to p53-3, a high wild-type p53 producer cell line established previously (Chen et al., 1996) . To determine the transcriptional activity of p53(D62 ± 91), we analysed the endogenous p21 gene, a known p53 target (el-Deiry et al., 1993) . Western blot analysis demonstrated that p21 was activated in both low and high p53(D62 ± 91) producer cells, but the level of induction was approximately 30% of that activated by wild-type p53 (Figure 1a ). This result suggests that the proline-rich domain may contribute to, but nevertheless is dispensable for, p53 transactivation. To determine whether p53(D62 ± 91) can induce cell cycle arrest, the growth rates of two high producer cell lines, p53(D62 ± 91)-5 and -6, were analysed. We found that cells expressing p53(D62 ± 91) failed to multiply (Figure 1b) or multiply slowly (Figure 1d ) while cells not expressing p53(D62 ± 91) showed a pattern of exponential growth (Figure 1b and d) . FACS analysis showed Figure 1 The proline-rich domain is required for p53-dependent apoptosis but not cell cycle arrest. To generate p53(D62 ± 91), cDNA fragments encoding amino acids 1-61 and 92-393 were ampli®ed independently and ligated together through an internal BamHI site which was arti®cially created without aecting the amino acid composition of the p53 protein. Primers used for the amino acids 1 ± 61 fragment were: forward primer N1: GAT CGA ATT CAC CAT GGG CTA CCC ATA CGA TGT TCC AGA TTA CGC TGA GGA GCC GCA GTC AGA TCC; and reverse primer C61: GAT CGG ATC CGG ACC TGG GTC TTC AGT. Primers used for the amino acid 92-393 fragment were: forward primer N92: GAT CGG ATC CCC TGT CAT CTT CTG TC; and reverse primer C393: GAT CGA ATT CTC AGT CTG AGT CAG GCC CCT. p53(D62 ± 91) was then cloned into the tetracyclineregulated expression vector, 10-3, at its EcoRI site and the resulting plasmid was used to generate cell lines that inducibly express p53 as previously described (Chen et al., 1996) . (a) Levels of p53, p21, and actin in p53-3, and p53(D62 ± 91)-1, -5, and -6 cells were assayed by Western blot analysis. Cell extracts were prepared from uninduced cells (7) or cells induced to express (+) wild-type p53 or p53(D62 ± 91). The upper portion of the blot was probed with a mixture of p53 monoclonal antibodies Pab421 and Pab240 and actin polyclonal antibody (Sigma, St Louis, MO, USA). Note that mutant p53(D62 ± 91) migrates faster than wild-type p53 because it is missing 30 amino acids. The lower portion of the blot was probed with p21 monoclonal antibody (Oncogene Science, Uniondale, NY, USA). (b and d) Growth rates of p53(D62 ± 91)-5 and -6 cells in the presence (^) or absence (&) of p53 were measured as previously described (Zhu et al., 1998) . (c and e) The percentages of p53(D62 ± 91)-5 and -6 cells in G 0 -G 1 , S, and G 2 -M phases in the presence or absence of p53 for 3 days were quantitated by FACS analysis as described previously (Zhu et al., 1998) . (f) Growth rates of H1299-24 cells in the presence (+tet) or absence (7tet) of tetracycline. The experiments were performed similarly as in (b) that the number of S-phase cells was markedly reduced in p53(D62 ± 91)-5 cells and moderately reduced in p53(D62 ± 91)-6 cells upon induction of p53 (Figure 1c and e). Thus, both growth rate and FACS analyses indicate that the proline-rich domain in p53 is not required for cell cycle arrest. As control, the growth rates of H1299-24 cell line was similarly established but does not express any protein were nearly identical in the presence (&+tet) or absence (^-tet) of tetracycline ( Figure 1f ).
It is well established that p53 can induce apoptosis in H1299 cells (Chen et al., 1996; Haupt et al., 1995) . This can be quantitated by determining the percentage of cells containing a sub-G 1 content of DNA. FACS analysis showed that only 2 ± 6% of cells underwent apoptosis after induction of p53(D62 ± 91) for 3 days as determined from three separate experiments. Using trypan blue exclusion assay (Zhu et al., 1998) , a similar percentage of dead cells were detected. In contrast, about 45% and 30% of cells underwent apoptosis after Figure 2 Deletion of the proline-rich domain abolished the apoptotic activity of the transactivation de®cient p53(gln22-ser23). p53(gln22-ser23/D62 ± 91) was generated similarly as p53(D62 ± 91) except that a cDNA encoding p53(gln22-ser23) was used as template. (a) Levels of p53, p21 and actin in p53-3 and p53(gln22-ser23/D62 ± 91)-2 and -14 cells were assayed by Western blot analysis. (b and d) Growth rates of p53(gln22-ser23D62 ± 91)-2 and -14 cells in the presence (^) or absence (&) of p53. (c and e) The percentage of p53(gln22-ser23D62 ± 91)-2 and -14 cells in G 0 -G 1 , S, and G 2 -M phases in the presence or absence of p53 for 3 days. The experiments were performed in an identical manner to those shown in Figure 1 induction of wild-type p53 and transactivation de®cient p53(gln22-ser23), respectively.
Previously, we and others have shown that p53(gln22-ser23) retains a partial apoptotic activity but is incapable of inducing cell cycle arrest (Chen et al., 1996; Haupt et al., 1995) . To further demonstrate the function of the proline-rich region, we hypothesized that p53(gln22-ser23/D62 ± 91), which contains a double point mutation at residues 22 and 23 in the activation domain as well as deletion of the proline-rich domain, would be unable to induce either cell cycle arrest or apoptosis. Four stable cell lines that inducibly express p53(gln22-ser23/D62 ± 91) were established and two representative cell lines were characterized ( Figure  2a ). We found that this p53 mutant is unable to activate p21 (Figure 2a) . Furthermore, growth rate (Figure 2b and d) and FACS (Figure 2c and e) analyses showed that neither cell cycle arrest nor apoptosis were observed in cells expressing p53(gln22-ser23/D62 ± 91) under the induced condition. These Figure 3 The N-terminal PXXP motif is necessary for mediating apoptosis. To generate p53(D74 ± 91), cDNA fragments encoding amino acids 1 ± 73 and 92 ± 393 were ampli®ed independently and ligated together through an internal KpnI site which was arti®cially created without aecting the amino acid composition of the p53 protein. Primers used for the amino acid 1 ± 73 fragment were: forward primer N1 as used for generating p53(D62 ± 91); and reverse primer C73: GAT CGG TAC CGG GGG AGC AGC CTC TGG. Primers used for the amino acids 92 ± 393 fragment were: forward primer N92-1: GAT CGG TAC CCC TGT CAT CTT CTG TC; and reverse primer C393 as used for generating p53(D62 ± 91). results indicate that the apoptotic activity of p53(gln22-ser23) is lost upon deletion of the proline-rich region. While the human p53 protein contains ®ve PXXP motifs, the rat and murine contain only one and two, respectively (Walker and Levine, 1996) . Thus, we investigated whether the dosage of the PXXP motifs can determine the extent of apoptotic response. To this end, we generated p53(D74 ± 91), which lacks the Cterminal four PXXP motifs. Ten stable cell lines were established that inducibly express this mutant and three representative cell lines were characterized (Figure 3a) . p53(D74 ± 91)-1 is a low p53 producer while p53(D74 ± 91)-10 and -17 are high p53 producers. Western blot analysis showed that p21 was moderately activated by p53(D74 ± 91), to approximately 50% of that activated by wild-type p53 (Figure 3a) . Nevertheless, this mutant can eciently induce cell cycle arrest as measured by the rate of cell growth (Figure 3b and d) or by the reduction of cells in S phase (Figure 3c and e) . In addition, we found that 10 ± 17% of cells underwent apoptosis as detected by FACS analysis. These results indicate that p53(D74 ± 91) retains a partial apoptotic activity.
Previously, it was shown that the p21 promoter can be activated by a PXXP deletion mutant to an extent that is equal to or greater than by wild-type p53 (Venot et al., 1998; Walker and Levine, 1996) . A similar result was observed when we tested the ability of p53(D62 ± 91) to activate the p21 promoter in a luciferase assay (data not shown). However, Western blot analysis consistently showed that p53(D62 ± 91) is much weaker than wild-type p53 to induce p21 (Figure 1a ; data not shown). To determine whether the low level of p21 protein detected in p53(D62 ± 91)-expressing cells is due to decreased expression of the p21 gene, we performed Northern blot analysis. We found that p21 was induced by p53(D62 ± 91) but the extent of induction was approximately 30% of that by wild-type p53 (Figure 4a ; Table 1 ). As controls, we used two previously characterized cell lines, p53(gln22-ser23)-2 and p53(R249S)-4 (Chen et al., 1996) , which inducibly express the transactivation de®cient p53(gln22-ser23) Figure 4 Deletion of the PXXP motifs dierentially aects p53 induction of endogenous target genes. Northern blots were prepared using 10 mg of total RNA isolated from uninduced cells (7) or cells induced induced to express (+) wild-type p53, p53(D62 ± 91), p53(gln22-ser23) and p53(R249S). Northern blot analysis was performed as described (Zhu et al., 1998) . The p21, MDM2, BAX, GADD45 and GADPH probes were prepared as described (Zhu et al., 1998) . The KILLER/DR5 cDNA probe (GenBank #159553) was purchased from American Type Culture Collection. The following cDNA probes were purchased from Genome System, Inc (St. Louis, MO, USA): BTG2 (GenBank #H86711), PIG1 (W61024), PIG2 (H18355), PIG3 (N75824), PIG4 (H45773), PIG6 (R88591), PIG8 (R42786), PIG10 (R87338), PIG11 (R54648), PIG12 (AA149234) and p85 (N21330) 
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Function of p53 proline-rich region J Zhu et al and tumor-derived mtuant p53(R249S), respectively. Both p53(gln22-ser23) and p53(R249S) were inert in inducing p21 (Figure 4a ; also see Table 1 ).
Next, we determined whether p53(D62 ± 91) can regulate other p53 target genes, i.e., MDM2, GADD45, BAX, BTG2, p85 and KILLER/DR5. We found that MDM2, an oncogene and a negative regulator of p53 (Wu et al., 1993) , was slightly induced by p53(D62 ± 91) (Figure 4b ; Table 1 ). However, GADD45, a DNA damage responsive gene involved in DNA repair and growth suppression (Kastan et al., 1992) , was substantially induced by p53(D62 ± 91) to an extent that is nearly two times more than by wild-type p53 (Figure 4c ; Table 1 ). It is well known that p21 is primarily responsible for p53-dependent cell cycle arrest. Thus, although the induction of p21 is compromised by deletion of the PXXP motifs, it is possible that an enhanced induction of GADD45 may compensate the decreased induction of p21, resulting in cell cycle arrest detected in p53(D62 ± 91)-expressing cells (Figure 1) . BAX, an apoptosis activator, can be weakly induced by wildtype p53 (Miyashita et al., 1994) as shown in this study ( Figure 4d ; Table 1 ). However, BAX expression was only slightly reduced by deletion of the PXXP motifs ( Figure 4d ; Table 1 ). BTG2, a nerve growth factor responsive gene that can cause growth suppression (Rouault et al., 1996) , was strongly induced by p53 but only slightly by p53(D62 ± 91) ( Figure 4e ; Table 1 ). p85, a regulatory subunit of the signaling protein phosphatidyl-3-OH kinase (PI(3)K), was shown to be involved in the p53-dependent apoptotic response to oxidative stress (Yin et al., 1998) . Upon H 2 O 2 treatment, the level of p85 was increased in a p53-dependent manner (Yin et al., 1998) . We found that p85 was induced 2 ± 3-fold by wild-type p53 but little if any by p53(D62 ± 91) ( Figure 4f ; Table 1 ). KILLER/DR5, a death receptor gene which can be induced by genotoxic stress and p53 (Wu et al., 1997) , was similarly induced by both wildtype p53 and p53(D62 ± 91) (Figure 4g ; Table 1 ).
Several redox-related genes (PIGs), that were shown to be activated by p53 and potentially involved in p53-dependent apoptotic pathway (Polyak et al., 1997) , were examined for p53(D62 ± 91) induction. We con®rmed that PIG2, PIG3, PIG6, PIG7, PIG8 and PIG11 were signi®cantly induced by wild-type p53 in H1299 cells (Figure 4h ± m; Table 1 ). We found that induction of PIG2, PIG7, and PIG8 was not signi®cantly aected by deletion of the proline-rich region (Figure 4h , k and m; Table 1 ) but induction of PIG3, PIG6 and PIG11 was substantially reduced or abrogated (Figures 3i, 4j and 4m ; Table 1 ). We also found that PIG10 and PIG12 were not substantially induced by p53, and PIG1 and PIG4 were undetectable in H1299 cells (data not shown). Therefore, p53(D62 ± 91) induction of the PIG1, PIG4, PIG10 and PIG12 genes was not analysed.
Our studies have con®rmed and extended the previous observation (Walker and Levine, 1996) that the proline-rich domain in human p53 is necessary for ecient growth suppression. Speci®cally, we found that the proline-rich domain is required for p53-dependent apoptosis. Thus, this function is conserved between human and murine p53 (Sakamura et al., 1997) . We also found that only the N-terminal PXXP motif is required for mediating apoptosis, indicating that the proline-rich domain contains redundant eector PXXP components. Furthermore, we have shown that the proline-rich domain can dierentially regulate p53 induction of endogenous target genes: deletion of the proline-rich domain has no signi®cant eects on induction of Bax, KILLER/DR5, PIG2, PIG7 and PIG8; however, induction of p21, MDM2, BTG2, p85, PIG3, PIG6, and PIG11 were substantially reduced or abrogated. Since p85 is involved in the apoptotic response to oxidative stress (Yin et al., 1998) and PIG3 and PIG6 can produce reactive oxygen species leading to degradation of mitochondria and subsequently apoptosis (Polyak et al., 1997) , the results suggest that the PXXP motifs in p53 are required for activating genes that participate directly in signaling pathways controlling apoptosis.
It should be noted that the dierential regulation of cellular target genes by p53(D62 ± 91) may not be uncovered if its transcriptional activity was measured by its capability of activating the p21 or other target gene promoters in a transient transfection assay. In addition to the p21 promoter, the MDM2, GADD45, and BAX promoters can be activated by p53 lacking the proline-rich domain as eciently as wild-type p53 (Venot et al., 1998 ; data not shown). Thus, we should not extrapolate the result observed by the promoter analysis of a target gene to p53 induction of the endogenous target gene. It is well established that the regulation of transcription for endogenous genes that are packaged into chromatin is dierent from those that are transiently transfected into cells in naked plasmids (Smith and Hager, 1997) . The simpli®ed explanation is that the promoter template in a naked plasmid would be easily accessible while that packaged into chromatin is not. It is well known that transcriptional activators function, at least in part, to counteract chromatin-mediated repression (Kadonaga, 1998) . For example, MyoD, a basic helix ± loop ± helix transcriptional activator, contains two domains that are necessary for chromatin remodeling but are not associated with any known activation function (Gerber et al., 1997) . While deletion of these two domains lead to very mild eects on activation of transiently transfected templates, activation of endogenous templates depends on these two domains of MyoD. Since the PXXP motifs in p53 have a function similar to these two domains in MyoD in dierentially activating transfected and endogenous templates, it suggests that the proline-rich region may be necessary for chromatin remodeling, which is responsible for p53 as transcriptional activator to counteract chromatin-mediated repression for some of the cellular p53 target genes, resulting in their dierential induction.
